SENIOR HEALTH Drug Information <Back to Last Page>

Related Resources

• Osteoporosis The Silent Bone Thinner • Osteoporosis - You talk Back • Understand Osteoporosis

Brand Name - Evista®

Generic Name - raloxifene hydrochloride

FDA Drug Classification - Selective estrogen receptor modulator

Action - Reduces reabsorption of bone and bone "turnover" which leads to bone loss known as osteoporosis

Adverse Effects -

• Hot flashes
• Weight gain
• Edema or swelling

Precautions - Should not be used by:

• Use with caution in women with circulatory disorders as it may increase risk of blood clots
• Use with caution in women experiencing abnormal uterine bleeding.

Interactions -

• Should not be used with Cholestyramine as it affects it's absorption.
• Monitor protrombin time if given to a patient on warfarin (coumadin)

If you have any questions or comments on senior health nutrition, fitness, etc., go to the Senior Health Forum where we are talking about the following:

Subscribe to the Newsletter
Name	Email

The information contained in these pages
is for educational / reference use only.